Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide

Details for Australian Patent Application No. 2005309808 (hide)

Owner Merck & Co., Inc.

Inventors Hamilton, Brian K.; Dokou, Eleni; Wuelfing, W. Peter; Gibson, Todd; Rhodes, Timothy; Alani, Laman L.; Deluca, Charles; Peresypkin, Andrey V.; Gandek, Thomas P.; Panmai, Santipharp; McKelvey, Craig; Euler, Danielle H.; Ostovic, Drazen

Agent Spruson & Ferguson

Pub. Number AU-A-2005309808

PCT Pub. Number WO2006/057903

Priority 60/630,746 24.11.04 US

Filing date 18 November 2005

Wipo publication date 1 June 2006

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/66 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/057903 Priority application(s): WO2006/057903

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309817-Rasagiline orally disintegrating compositions

2005309807-2alpha-methyl-19-nor-1alpha-hydroxy-h omopregnacalciferol and its uses